Elaine K Chan, PharmD
Executive Director and Head of Medical Affairs
Dr. Elaine Chan heads Medical Affairs at Scilex, since 2022. Prior to joining Scilex, Dr. Chan was Senior Director at Genentech Inc (a member of the Roche group), one of the world’s leading pharmaceutical companies, from 2009 to 2021, where she held wide-ranging roles in Medical Affairs, Business Operations and Strategy, Pharmacovigilance, Marketing and new product planning. While at Genentech, Dr. Chan was involved in the development and launch of several market-leading brands, including Gazyva (Obinutuzumab) and Susvimo (Ranibizumab injection for Ocular Implant).
Dr. Chan has over a decade of experience working at small-midsize biotech companies, including PDL BioPharma (now Abbvie) and Chiron (now Novartis International AG), where she led Marketing and Product Strategy for Phase 3 Molecules in Hepatology and Lung Transplantation, two niche and underserved markets. Dr. Chan participated in four product pre-launches, two as leads (Terlipressin and Tenecteplase), and has a proven track record of delivering successful outcomes for patients and stakeholders.
Dr. Chan holds a Doctorate of Pharmacy (PharmD) from the University of California, San Francisco (UCSF), where she received extensive training in Clinical Pharmacology and Therapeutics.